Incyte (INCY) Change in Acquisitions & Divestments (2010 - 2026)

Incyte (INCY) reported Change in Acquisitions & Divestments of $69.7 million for Q1 2026, up 53.21% on a YoY basis from $45.5 million in Q1 2025, and down 7.05% quarter-over-quarter from $75.0 million in Q4 2025.

Incyte (INCY) Change in Acquisitions & Divestments (2010 - 2026) Analysis & Trends

Incyte has reported Change in Acquisitions & Divestments for 17 years, with the latest figure at $69.7 million in Q1 2026.

  • For the quarter ending Q1 2026, Change in Acquisitions & Divestments rose 53.21% year-over-year to $69.7 million; the trailing twelve-month figure through Mar 2026 stood at $308.8 million (up 76.97% YoY), and the FY2025 full-year result was $284.6 million, up 23.07% from the prior year.
  • Change in Acquisitions & Divestments for Q1 2026 stood at $69.7 million, down from $75.0 million in the prior quarter.
  • The five-year high for Change in Acquisitions & Divestments was $107.8 million in Q3 2025, with the low at $258000.0 in Q1 2022.
  • Historically, Change in Acquisitions & Divestments has averaged $57.1 million across 5 years, with a median of $56.3 million in 2025.
  • Annual changes were most pronounced in 2022 — Change in Acquisitions & Divestments slumped 99.27% — and 2023, when it soared 20515.89%.
  • Incyte's Change in Acquisitions & Divestments stood at $21.2 million in 2022, then jumped by 285.38% to $81.6 million in 2023, then tumbled by 71.32% to $23.4 million in 2024, then jumped by 220.63% to $75.0 million in 2025, then declined by 7.05% to $69.7 million in 2026.
  • The last three Change in Acquisitions & Divestments figures came in at $69.7 million (Q1 2026), $75.0 million (Q4 2025), and $107.8 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Incyte 19.62 Bn 15.60 Bn 1.17 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 69.70 Mn
Mar 31, 2026 69.70 Mn
Dec 31, 2025 74.99 Mn
Dec 31, 2025 74.99 Mn
Sep 30, 2025 107.84 Mn
Sep 30, 2025 107.84 Mn
Jun 30, 2025 56.31 Mn
Jun 30, 2025 56.31 Mn
Mar 31, 2025 45.49 Mn
Mar 31, 2025 45.49 Mn
Dec 31, 2024 23.39 Mn
Dec 31, 2024 23.39 Mn
Sep 30, 2024 25.25 Mn
Sep 30, 2024 25.25 Mn
Jun 30, 2024 80.39 Mn
Jun 30, 2024 80.39 Mn
Mar 31, 2024 102.25 Mn
Mar 31, 2024 102.25 Mn
Dec 31, 2023 81.56 Mn
Dec 31, 2023 81.56 Mn